On-Chip Drug Screening and Nanomedicine Applications via (L)SPR

Microfluidic lab-on-a-chip tools have been emerged in recent years as next generation nanomedicine and drug screening platforms. Plasmonic microfluidic systems have shown promising progress over the past years to identify potential drug candidates. These systems allow the study of drug interactions at molecular and cellular level while facilitating fast, sensitive and label-free detection. We foresee that the advancements in Surface Plasmon Resonance (SPR) coupled microfluidic systems will be an easy to use and cost-effective alternative to identify potential drug candidates for drug development process.